147 results
Page 4 of 8
8-K
EX-99.1
rdespcvd0 r5sdv
17 Jun 21
Synlogic Enters Research Collaboration with Roche for Development of Novel Therapy to Treat Inflammatory Bowel Disease
7:35am
8-K
EX-99.1
kjke wtgpub3sy
13 May 21
Synlogic Reports First Quarter Financial Results and Provides Business Update
6:46am
8-K
EX-1.1
a6qm7
16 Apr 21
Synlogic Announces Proposed Public Offering of Common Stock
8:35am
8-K
EX-99.1
iay5sze9yfbr rq2bjc
16 Apr 21
Synlogic Announces Proposed Public Offering of Common Stock
8:35am
8-K
EX-99.2
qxg7ym35
16 Apr 21
Synlogic Announces Proposed Public Offering of Common Stock
8:35am
8-K
EX-99.1
hwj gfu13mb
14 Apr 21
Synlogic Presents Data from SYNB1891 Phase 1 Trial at American Association for Cancer Research (AACR) Annual Meeting
12:00am
8-K
EX-99.2
sxezlj
14 Apr 21
Synlogic Presents Data from SYNB1891 Phase 1 Trial at American Association for Cancer Research (AACR) Annual Meeting
12:00am
8-K
EX-99.1
5x2egrwv
25 Mar 21
Synlogic Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
8:04am
8-K
EX-99.3
mpk elbh4
25 Mar 21
Synlogic Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
8:04am
8-K
EX-99.2
k7nacc
25 Mar 21
Synlogic Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
8:04am
8-K
EX-99.1
td1jqkgv9oid0c eyx8
24 Mar 21
Synlogic Announces SYNB8802 Will Advance to Phase 1B Proof of Concept Study After Proof of Mechanism Demonstrated in Dietary Hyperoxaluria
4:59pm
8-K
EX-99.1
orazg50ouipg suqy9
8 Mar 21
Synlogic Announces Promotion of Dr. Caroline Kurtz to Chief Development Officer and Strengthening of Leadership Team
7:25am
8-K
EX-99.1
nv6p0hp
10 Feb 21
Synlogic Appoints Lisa Kelly-Croswell to its Board of Directors
9:04am
8-K
EX-99.1
ii6v1d75t0 tlc
14 Dec 20
Results of Operations and Financial Condition
6:03am
8-K
EX-99.1
qwg0p1xxudze51j6mxy
10 Dec 20
Synlogic Appoints Michael Heffernan to its Board of Directors
12:00am
8-K
EX-99.3
glh0 3lwrnqbgs0
5 Nov 20
Synlogic Initiates Phase 1 Study of SYNB8802 for the Treatment of Enteric Hyperoxaluria
6:31am
8-K
EX-99.2
3uim4716qa e9q4
5 Nov 20
Synlogic Initiates Phase 1 Study of SYNB8802 for the Treatment of Enteric Hyperoxaluria
6:31am